• SENSEX 75,364.69
    -930.67 (--1.22%)
  • BANKNIFTY 51,502.70
    -94.65 (--0.18%)
  • Tata Motors
    610.10 606.20(%)
  • Hind.Aeronautics
    4,205.05 3,045.95(%)
  • Reliance Industr
    1,192.85 1,156.00(%)
  • Hindalco Inds.
    596.75 558.00(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Vedanta
    398.20 301.70(%)
  • Mazagon Dock
    2,535.80 1,046.00(%)
  • TCS
    3,295.60 3,295.60(%)
  • Suzlon Energy
    54.70 37.95(%)
  • Bajaj Finance
    8,796.70 9,258.95(%)
  • Infosys
    1,448.00 1,359.10(%)
  • Interglobe Aviat
    5,150.65 5,187.00(%)
  • Jio Financial
    220.80 198.60(%)
  • Vodafone Idea
    7.85 6.60(%)
  • HDFC Bank
    1,842.20 1,880.00(%)
  • Angel One
    2,271.05 1,942.00(%)
  • O N G C
    224.25 215.20(%)
  • Tata Steel
    140.00 122.60(%)
  • Larsen & Toubro
    3,238.00 3,141.30(%)
  • ICICI Bank
    1,338.00 1,372.50(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zenith Drugs Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 92356.0
  • ISIN : INE0QWN01013
94.95 -7 (-6.68%)
  • As on 06 Apr 2025 (EOD)

  • Today’s Low

    93.05

  • Today’s High

    107.00

  • Open

    103.00

  • Perv Close

    101.75

  • 52W Low

    47.15

  • 52W High

    154.40

Key Indicators

  • P/E(TTM)

    15.41

  • Mar.Cap (₹Cr.)

    162.83

  • Div & Yield %

    0.53

  • Book Value(₹)

    36.28

  • Debt-Equity Ratio

    -6.68

  • AGM Date

    04-Apr-2025

  • EPS

    6.16

  • P/E Ratio

    15.41

Financials Ratios

  • Debt-Equity Ratio

    0.63

  • Mar.Cap (₹Cr.)

    162.83

  • RONW (%)

    24.13

  • ROCE (%)

    25.16

Score Board

  • Equity (₹ in Cr.)

    17.15

  • BV (₹)

    36.30

  • Sales( ₹ in Cr.)

    131.62

  • NP (in Cr.)

    10.57

  • NP Var(%)

    117.0

  • Div%

    5.0

  • CPS (₹)

    6.90

  • EPS (₹)

    6.20

  • Traded Value (₹ in Lakhs)

    162.83

  • 52 Week High

    154.40

  • 52 Week Low

    47.15

  • Price BSE

    0.0

  • Price NSE

    95.00

  • Market Capital( in Cr.)

    162.83

  • P/C Ratio

    13.70

  • P/E Ratio

    15.40

  • Price Vs.BV

    6.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 131.62 114.52 91.66 81.12 85.94 -
Excise Duty 131.62 114.52 91.66 81.12 85.18 -
Net Sales 131.62 114.52 91.66 81.12 85.94 -
Other Income 2.12 1.24 0.95 0.11 0.06 -
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 -
Total Income 133.74 115.76 92.60 73.52 78.33 -
EXPENDITURE :
Raw Materials 131.62 114.52 91.66 81.12 85.18 -
Power & Fuel Cost 131.62 114.52 91.66 81.12 85.18 -
Employee Cost 6.09 4.96 3.85 3.48 4.47 -
Other Manufacturing Expenses 15.21 15.38 1.89 0.16 0.79 -
Selling & Administrative Expenses 0.00 0.00 3.99 10.15 8.67 -
Miscellaneous Expenses 15.21 15.38 1.89 0.16 0.79 -
Less : Pre-operative Expenses Capitalised :
Total Expenditure 119.00 109.10 88.20 68.92 73.46 -
Operating Profit 7.90 7.00 2.49 4.57 3.27 -
Interest 3.00 2.33 2.14 1.49 1.31 -
Gross Profit 14.74 6.66 4.40 4.60 4.88 -
Depreciation 1.30 1.30 1.34 1.22 0.92 -
Profit Before Tax 14.74 6.66 4.40 4.60 4.88 -
Tax 3.85 1.76 1.24 1.36 1.51 -
Fringe Benefit tax -1.45 0.00 0.00 0.00 0.00 -
Deferred Tax -0.24 -0.05 -0.05 0.17 -0.04 -
Reported Net Profit 9.54 4.88 3.21 3.07 3.40 -
Extraordinary Items 14.74 6.66 4.40 4.60 4.88 -
Adjusted Net Profit 9.54 4.88 3.21 3.07 3.40 -
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 -
Statutory Appropriations 0.86 0.00 0.00 0.00 0.00 -
P & L Balance carried down 9.54 4.88 3.21 3.07 3.40 -
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 5.00 0.00 0.00 0.00 0.00 -
Dividend Per Share(Rs) 0.50 0.00 0.00 0.00 0.00 -
Earnings Per Share-Unit Curr 5.56 122.03 80.32 76.66 85.00 -
Book Value 0.86 0.00 0.00 0.00 0.00 -
Book Value(Adj)-Unit Curr 0.86 0.00 0.00 0.00 0.00 -

Shareholding Pattern

  • Promoter Group

    69.98%

  • Public Share Holding

    30.02%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,000,000 69.98 12,000,000 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 12,000,000 69.98 12,000,000 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 72,000 0.42 72,000 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 72,000 0.42 72,000 4
2] Non Institution
Bodies Corporate 300,800 1.75 300,800 21
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 169,600 0.99 169,600 38
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,387,200 8.09 1,387,200 21
Individuals holding nominal share capital up to Rs. 1 lakh 2,998,400 17.48 2,998,400 1,197
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 220,800 1.29 220,800 67
Sub Total 5,076,800 29.60 5,076,800 1,344
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 17,148,800 100.00 17,148,800 1,355

Company Background

Zenith Drugs LtdPharmaceuticals - Indian - Formulations

  • Zenith Drugs Ltd
  • BSE Code : 92356.0
  • ISIN : INE0QWN01013

  • Incorporation Year

    2000

  • Registered Office

    K # 72/5 Village Muradpura
    NA Depalpur, Indore,
    Madhya Pradesh-453001

  • Telephone

    +91 84355 01867

  • FAX

  • Chairman

  • Managing Director

    Sandeep Bhardwaj

  • Company Secretary

    Sakshi Bhawsar

  • Auditor

    VDS & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Zenith Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zenith 94.95 133.74 131.62 17.08 27.46
Abbott India 29,049.10 6,097.18 5,848.91 46.26 44.71
Astrazeneca Phar 7,908.50 1,330.33 1,295.53 203.88 33.26
P & G Health Ltd 5,225.45 1,166.89 1,151.26 36.66 39.76
Glaxosmi. Pharma 2,735.75 3,530.73 3,407.25 54.40 44.44
Cipla 1,415.55 17,645.00 16,574.34 24.27 20.10
Amrutanjan Healt 644.45 437.58 421.23 37.78 20.84
Fermenta Biotec. 283.95 315.24 307.09 26.91 4.10
Guj. Themis Bio. 261.90 174.19 169.82 54.22 44.82
Bliss GVS Pharma 120.00 638.96 605.46 27.46 11.19
Ambalal Sarabhai 38.10 11.70 3.81 16.28 1.92